Brette L. Trost
Lawyers
Filters
Centogene strategic collaboration with Lifera
We are advising Centogene on its joint venture with and convertible debt investment by Lifera
Estée Lauder $2 billion senior notes offering
The investment-grade notes are due 2028, 2033 and 2053
TPG acquisition of majority stake in Thomson Reuters’ Elite business
We are advising TPG on the transaction
Alteryx $450 million senior notes offering
The 8.75% notes are due 2028
CureVac $250 million follow-on offering
We advised CureVac on the equity offering
Precigen $75 million follow-on offering
We advised Precigen on the SEC-registered offering
Ferrero Group acquisition of Wells Enterprises
We are advising Ferrero on the transaction
Biodesix $40 million follow-on offering
The shares are listed on the Nasdaq Global Market
TMS ¥2.9 billion global IPO
The shares are listed on the Tokyo Stock Exchange
Prime Medicine $175 million IPO
The shares are listed on the Nasdaq Global Market